Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor

Matthew D. Merrell, Jonathan P. Jackson, Lisa M. Augustine, Craig D. Fisher, Angela L. Slitt, Jonathan M. Maher, Wendong Huang, David D. Moore, Youcai Zhang, Curtis D. Klaassen and Nathan J. Cherrington
Drug Metabolism and Disposition August 2008, 36 (8) 1716-1721; DOI: https://doi.org/10.1124/dmd.108.020867
Matthew D. Merrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan P. Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa M. Augustine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig D. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela L. Slitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan M. Maher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendong Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David D. Moore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youcai Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis D. Klaassen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan J. Cherrington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 8 1716-1721
DOI 
https://doi.org/10.1124/dmd.108.020867
PubMed 
18474683

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 7, 2008
  • Accepted May 7, 2008
  • Published online July 21, 2008.

Article Versions

  • Earlier version (May 12, 2008 - 11:32).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Matthew D. Merrell,
  2. Jonathan P. Jackson,
  3. Lisa M. Augustine,
  4. Craig D. Fisher,
  5. Angela L. Slitt,
  6. Jonathan M. Maher,
  7. Wendong Huang,
  8. David D. Moore,
  9. Youcai Zhang,
  10. Curtis D. Klaassen and
  11. Nathan J. Cherrington
  1. Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (M.D.M., J.P.J., L.M.A., C.D.F., N.J.C.); Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island (A.L.S.); Tsukuba Advanced Research Alliance Center, University of Tsukuba Tennoudai, Tsukuba-shi, Ibaraki, Japan (J.M.M.); Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (W.H., D.D.M.); and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (Y.Z., C.D.K.)
  1. Address correspondence to:
    Nathan J. Cherrington, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721. E-mail: cherrington{at}pharmacy.arizona.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 20170189
Sep 20172120
Oct 20171245
Nov 20171185
Dec 20175135
Jan 20182131
Feb 20182145
Mar 20180121
Apr 20182214
May 20181245
Jun 20181171
Jul 20180102
Aug 20180135
Sep 20180233
Oct 201801212
Nov 20180102
Dec 20182153
Jan 2019811
Feb 20192601
Mar 20191411
Apr 20191208
May 20191537
Jun 20191215
Jul 2019833
Aug 20191701
Oct 20191033
Nov 20191501
Dec 20192039
Jan 20202501
Feb 20201013
Mar 20201302
May 20201200
Jun 20201213
Jul 20201212
Aug 20201014
Sep 20201305
Oct 20202702
Nov 20201439
Dec 20201621
Jan 20211843
Feb 20211233
Mar 20211431
Apr 20211510
May 20213421
Jun 20211040
Jul 20211922
Aug 20211332
Sep 20211821
Oct 20211841
Nov 20211931
Dec 20212732
Jan 20221711
Feb 20221830
Mar 20221922
Apr 20221561
May 20222054
Jun 20222001
Jul 202226511
Aug 20221410
Sep 20222474
Oct 20221571
Nov 20221621
Dec 20221125
Jan 20233121
Feb 20232315
Mar 20231910
Apr 2023544
May 20231542

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (8)
Drug Metabolism and Disposition
Vol. 36, Issue 8
1 Aug 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor

Matthew D. Merrell, Jonathan P. Jackson, Lisa M. Augustine, Craig D. Fisher, Angela L. Slitt, Jonathan M. Maher, Wendong Huang, David D. Moore, Youcai Zhang, Curtis D. Klaassen and Nathan J. Cherrington
Drug Metabolism and Disposition August 1, 2008, 36 (8) 1716-1721; DOI: https://doi.org/10.1124/dmd.108.020867

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor

Matthew D. Merrell, Jonathan P. Jackson, Lisa M. Augustine, Craig D. Fisher, Angela L. Slitt, Jonathan M. Maher, Wendong Huang, David D. Moore, Youcai Zhang, Curtis D. Klaassen and Nathan J. Cherrington
Drug Metabolism and Disposition August 1, 2008, 36 (8) 1716-1721; DOI: https://doi.org/10.1124/dmd.108.020867
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Sex- and lifestyle-related factors affect hepatic CYP levels
  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics